Акушерство, гинекология и репродукция (Mar 2021)

Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice

  • K. N. Grigoreva,
  • V. O. Bitsadze,
  • J. Kh. Khizroeva,
  • M. V. Tretyakova,
  • D. A. Ponomarev,
  • K. Yu. Tsvetnova,
  • D. A. Doronicheva,
  • A. R. Mamaeva,
  • K. V. Mekhedova,
  • G. Rizzo,
  • J.-C. Gris,
  • I. Elalamy,
  • A. D. Makatsariya

DOI
https://doi.org/10.17749/2313-7347/ob.gyn.rep.2021.203
Journal volume & issue
Vol. 15, no. 1
pp. 93 – 106

Abstract

Read online

ADAMTS-13 is a crucial metalloproteinase involved in liberating fragments of von Willebrand factor (vWF) into the plasma as well as regulating its activity by cleaving "ultra-large" multimers into smaller and less active counterparts. Many pathological conditions, including those emerged during pregnancy are characterized by increased level of vWF and decreased ADAMTS-13 activity. In this regard, it is necessary to monitor the levels of vWF and ADAMTS-13 activity to prevent thrombotic thrombocytopenic purpura (Moschcowitz disease) as one of the most severe forms of thrombotic microangiopathy.

Keywords